VTYX
Income statement / Annual
Last year (2023), Ventyx Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Ventyx Biosciences, Inc.'s net income was -$192.96 M.
See Ventyx Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$941,000.00 |
$470,000.00 |
$30,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$941,000.00 |
-$470,000.00 |
-$30,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$175.77 M
|
$87.74 M
|
$58.48 M
|
$6.37 M
|
$3.55 M
|
| General & Administrative
Expenses |
$32.23 M
|
$25.40 M
|
$8.67 M
|
$684,000.00
|
$628,000.00
|
| Selling & Marketing
Expenses |
$1.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$32.23 M
|
$25.40 M
|
$8.67 M
|
$684,000.00
|
$628,000.00
|
| Other Expenses |
$0.00 |
$41,000.00 |
-$5.45 M |
-$1,000.00 |
-$1,000.00 |
| Operating Expenses |
$207.99 M |
$113.14 M |
$67.15 M |
$7.05 M |
$4.18 M |
| Cost And Expenses |
$207.99 M |
$113.14 M |
$67.15 M |
$7.05 M |
$4.18 M |
| Interest Income |
$15.07 M |
$4.67 M |
$78,000.00 |
$358.00 |
$146.00 |
| Interest Expense |
$0.00 |
$0.00 |
$99,000.00 |
$358,000.00 |
$146,000.00 |
| Depreciation &
Amortization |
$158,000.00
|
$470,000.00
|
$30,000.00
|
$7.05 M
|
$4.18 M
|
| EBITDA |
-$207.84 M
|
-$107.96 M
|
-$67.12 M
|
$0.00
|
-$1,000.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$15.03 M
|
$4.71 M
|
-$16.60 M
|
-$21.12 M
|
-$147,000.00
|
| Income Before Tax |
-$192.96 M |
-$108.43 M |
-$83.75 M |
-$28.17 M |
-$4.33 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$470,000.00 |
-$5.38 M |
$358,000.00 |
$146,000.00 |
| Net Income |
-$192.96 M |
-$107.96 M |
-$78.37 M |
-$28.53 M |
-$4.47 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-3.3 |
-2.06 |
-1.55 |
-0.57 |
-0.0889 |
| EPS Diluted |
-3.3 |
-2.06 |
-1.55 |
-0.57 |
-0.0889 |
| Weighted Average Shares
Out |
$58.54 M
|
$52.47 M
|
$50.41 M
|
$50.30 M
|
$50.30 M
|
| Weighted Average Shares
Out Diluted |
$58.54 M
|
$52.47 M
|
$50.41 M
|
$50.30 M
|
$50.30 M
|
| Link |
|
|
|
|
|
